10x Genomics logo
10x Genomics
TXG | NASDAQ
Chart Builder DCF Calculator
$54.99
-$3.20 (-5.50%)
At close: Nov 16, 2026, 4:00 PM ET
$54.51
-$0.48 (-0.87%)
After-hours: Nov 16, 2026, 7:55 PM ET

10x Genomics Company Profile

Company profile explained

Company Profile

Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.

Key Executives

Name Position
Serge Saxonov Co-Founder, Chief Executive Officer & Director
Adam S. Taich Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer
Michael Schnall-Levin Founding Scientist & Chief Technology Officer
Benjamin J. Hindson Co-Founder, President, Chief Scientific Officer & Director
Cassie Corneau Manager of Investor Relations & Strategic Finance
Jens Durruthy Associate Director of Product Management
Jim Goodrich Chief of Global Operations
Mennah Moustafa Chief Commercial Officer
Randy Wu General Counsel and Secretary

Latest SEC Filings

Date Type Title
Oct 07, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 24, 2026 4 Filing
Sep 24, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 08, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Sep 03, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 26, 2026 4 Filing
Aug 26, 2026 4 Filing
View All SEC Filings ➞
10x Genomics
10x Genomics logo
Country United States
IPO Date Sep 12, 2019
Industry Biotechnology
Sector Healthcare
Employees 1,178
CEO Serge Saxonov

Contact Details

6230 Stoneridge Mall Road Pleasanton, California 94588-3260 United States

Stock Details

Ticker Symbol TXG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001770787
CUSIP Number 88025U109
ISIN Number US88025U1097
SIC Code 3826

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.